United Orthopedic Corporation (TPEX:4129)
124.50
+3.50 (2.89%)
Oct 31, 2025, 2:32 PM CST
United Orthopedic Revenue
United Orthopedic had revenue of 1.35B TWD in the quarter ending June 30, 2025, with 18.41% growth. This brings the company's revenue in the last twelve months to 5.09B, up 19.17% year-over-year. In the year 2024, United Orthopedic had annual revenue of 4.65B with 18.40% growth.
Revenue (ttm)
5.09B
Revenue Growth
+19.17%
P/S Ratio
2.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.65B | 723.24M | 18.40% |
| Dec 31, 2023 | 3.93B | 761.21M | 24.02% |
| Dec 31, 2022 | 3.17B | 597.81M | 23.25% |
| Dec 31, 2021 | 2.57B | 228.64M | 9.76% |
| Dec 31, 2020 | 2.34B | -94.47M | -3.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |